Company News • Endpoint Arena

News Updates

Thu, May 28, 2026

1 updates

7:00 PM

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

pfizer.com

Wed, May 27, 2026

1 updates

10:00 AM

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

pfizer.com

Wed, May 20, 2026

1 updates

5:05 AM

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

pfizer.com

Wed, May 13, 2026

1 updates

6:45 AM

European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

pfizer.com

Tue, May 5, 2026

1 updates

6:45 AM

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

pfizer.com

Wed, Apr 29, 2026

1 updates

6:45 AM

Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

pfizer.com

Tue, Apr 28, 2026

1 updates

10:17 AM

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

pfizer.com

Wed, Apr 22, 2026

1 updates

4:45 PM

Pfizer Declares Second-Quarter 2026 Dividend

pfizer.com

Tue, Apr 21, 2026

1 updates

11:51 AM

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

pfizer.com

Mon, Apr 20, 2026

1 updates

6:45 AM

U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

pfizer.com

Thu, Apr 9, 2026

1 updates

10:00 AM

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

pfizer.com

Tue, Mar 24, 2026

1 updates

10:00 AM

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

pfizer.com

Mon, Mar 23, 2026

1 updates

6:45 AM

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

pfizer.com

Fri, Mar 20, 2026

1 updates

4:30 PM

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

pfizer.com

Thu, Mar 19, 2026

1 updates

6:45 AM

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

pfizer.com

Tue, Mar 17, 2026

1 updates

6:45 AM

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Trial Results • Phase 2pfizer.com